SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-052647
Filing Date
2010-03-10
Accepted
2010-03-10 16:20:24
Documents
8
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1015004
2 CERTIFICATE OF INCORPORATION AS AMENDED ON MAY 28, 2009 dex31.htm EX-3.1 23990
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1843
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex232.htm EX-23.2 1620
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 7772
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 7799
7 CERTIFICATION OF CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 2887
8 CERTIFICATION OF CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 2935
  Complete submission text file 0001193125-10-052647.txt   1065316
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51462 | Film No.: 10670775
SIC: 2836 Biological Products, (No Diagnostic Substances)